Collegium Pharmaceutical, Inc (COLL)

Last Three Months

25-Aug-24 -- 24-Nov-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Drugs - Generic

Drugs

Insider Trading Sentiment: Strong Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

2

(1)

23

0

1

+1

0

+2

0

+3

Two Year Chart

25-Nov-22 -- 24-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
06-Sep-24 5:52 PM View:	06-Sep-24 Sale ($36.59K)	Kuhlmann Shirley R. EVP and General Counsel		Collegium Pharmaceutical, Inc - COLL	(15%) 139.41K to 119.18K	0	0	--	--	Show Txns Hide Txns

17-Sep-24 4:32 PM View:	13-Sep-24 Private Sale ($351.32K)	Smith Thomas B EVP and Chief Medical Officer		Collegium Pharmaceutical, Inc - COLL	(15%) 63.41K to 53.82K	0	0	--	--	Show Txns Hide Txns

14-Nov-24 4:50 PM View:	12-Nov-24 Grant 0	Karnani Vikram President and CEO Director		Collegium Pharmaceutical, Inc - COLL	100% 0 to 105.97K	0	0	--	--	Show Txns Hide Txns